Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nurix Therapeutics Inc shares valued at $57,554 were sold by van Houte Hans on Oct 30 ’24. At $24.30 per share, van Houte Hans sold 2,368 shares. The insider’s holdings dropped to 37,270 shares worth approximately $0.9 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hansen Gwenn sold 3,437 shares, netting a total of over 83,536 in proceeds. Following the sale of shares at $24.30 each, the insider now holds 50,670 shares.
Before that, Ring Christine had sold 4,182 shares from its account. In a trade valued at $101,644, the Chief Legal Officer traded Nurix Therapeutics Inc shares for $24.30 each. Upon closing the transaction, the insider’s holdings decreased to 4,182 shares, worth approximately $0.68 million.
As published in their initiating research note from UBS on October 24, 2024, Nurix Therapeutics Inc [NRIX] has been a Buy and the price target has been revised to $35. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. Earlier on July 31, 2024, Truist initiated its rating. Their recommendation was “a Buy” for NRIX stock.
Analyzing NRIX Stock Performance
During the last five days, there has been a drop of approximately -2.87%. Over the course of the year, Nurix Therapeutics Inc shares have jumped approximately 133.24%. Shares of the company reached a 52-week high of $27.60 on 10/28/24 and a 52-week low of $7.65 on 01/29/24. A 50-day SMA is recorded $24.16, while a 200-day SMA reached $17.59. Nevertheless, trading volume fell to 0.76 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Nurix Therapeutics Inc (NRIX)
According to the 24-hour chart, there is a support level at 23.55, which, if violated, would cause prices to drop to 23.03. In the upper region, resistance lies at 25.00. The next price resistance is at 25.93. RSI (Relative Strength Index) is 48.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.08, which suggests the price will decrease in the coming days. Percent R is at 72.63%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
